Tobias Dechow

FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy.

Markus Schwaiger, Andreas Buck, Axel Walch, 2012, Cancer research.

A Pilot Study to Evaluate 3′-Deoxy-3′-18F-Fluorothymidine PET for Initial and Early Response Imaging in Mantle Cell Lymphoma

Andreas K. Buck, Tibor Schuster, Markus Schwaiger, 2011, The Journal of Nuclear Medicine.

Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL

Andreas K. Buck, Tibor Schuster, Markus Schwaiger, 2014, Oncotarget.

[18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner

Andreas K. Buck, Tibor Schuster, Markus Schwaiger, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Dissection of PIM serine/threonine kinases in FLT3-ITD–induced leukemogenesis reveals PIM1 as regulator of CXCL12–CXCR4-mediated homing and migration

Stefan Knapp, Andrea Biondi, Antonello Villa, 2009, The Journal of experimental medicine.

Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches

Tom Stargardt, Andreas K. Buck, Ken Herrmann, 2010, Journal of Nuclear Medicine.

Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

Falko Fend, Tibor Schuster, Markus Schwaiger, 2007, Clinical Cancer Research.

Imaging Proliferation to Monitor Early Response of Lymphoma to Cytotoxic Treatment

Andreas K. Buck, Falko Fend, Tibor Schuster, 2008, Molecular Imaging and Biology.

Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine.

Markus Schwaiger, Ken Herrmann, Hans-Jürgen Wester, 2009, Methods.